I now have comprehensive information from Braunwald's Heart Disease and the Clinical Echocardiography textbook. Let me compile the full answer:
ASD, VSD, and PDA Device Closure: Devices, Deployment, and Defect Sizing
Overview
These are the three most common congenital heart defects (CHDs) amenable to transcatheter (percutaneous) device closure — avoiding open-heart surgery. All rely on a catheter introduced via the femoral vein/artery, guided by echocardiography (TEE/ICE) and fluoroscopy.
1. Atrial Septal Defect (ASD) Closure
What is an ASD?
An opening in the interatrial septum causing left-to-right shunting, leading to RV dilation and, if left unrepaired, pulmonary hypertension by the sixth decade. Incidence: 56–100 per 100,000 live births.
Types amenable to device closure:
- Secundum ASD — most common, located in the fossa ovalis region ✅ ideal for transcatheter
- Patent Foramen Ovale (PFO) — transcatheter closure FDA-approved for cryptogenic stroke ✅
- Superior sinus venosus ASD — now treated with covered stent in SVC-RA junction
- Primum ASD / Inlet ASD — not amenable; require surgical repair
ASD Closure Devices
| Device | Key Features |
|---|
| Amplatzer Septal Occluder (ASO) (Abbott) | Nitinol mesh, self-centering, dual discs with central waist filled with Dacron polyester. Sizes 4–40 mm waist diameter |
| Amplatzer Cribriform | No waist — not self-centering; ideal for multifenestrated defects and small central defects with satellite holes |
| Amplatzer PFO Occluder | Two nitinol discs, RA disc larger than LA disc, short fixed waist. FDA-approved for cryptogenic stroke |
| GORE Cardioform Septal Occluder (GSO) | 5-wire nitinol frame + ePTFE membrane. Non-self-centering. Closes defects up to 18 mm |
| GORE Cardioform ASD Occluder (GCA) | ePTFE-covered nitinol; "intra-disc occluder" expands to fit defect shape. Sizes 27–48 mm; treats defects 8–35 mm. No erosion risk — safe with deficient retro-aortic rim |
Step-by-step echocardiographic/diagrammatic view of ASD device deployment including balloon-assisted technique
ASD Sizing — Critical Steps
Step 1 — Echocardiographic (static) measurement:
- TEE or TTE measures the ASD diameter in multiple planes (bicaval view, short-axis view, 4-chamber view)
- 3D echocardiography provides the best spatial assessment of defect shape and rim adequacy
- Rim assessment is essential: a rim <5 mm ("deficient rim") — especially the retro-aortic rim — complicates device placement and increases erosion risk with the ASO
Step 2 — Balloon sizing (Stop-Flow Technique):
- A compliant sizing balloon (e.g., NuMed Sizing Balloon) is advanced across the ASD via the delivery sheath
- The balloon is inflated with dilute contrast under TEE/fluoroscopic guidance
- Inflation continues until the left-to-right shunt stops completely (stop-flow endpoint) — verified by color Doppler
- The stretched diameter of the balloon at this exact point is measured fluoroscopically
- ⚠️ Do NOT overinflate beyond cessation of shunt — overinflation overstates the true defect size and risks erosion
Panel (a): balloon sized at 18.5 mm. Panel (b): device crossing the septum. Panel (c): 20 mm Amplatzer fully deployed.
Step 3 — Device size selection:
- ASO: Choose device = same size as stop-flow diameter, or at most 1 size larger
- Maximum: Device ≤ 1.5× the echocardiographic (static) ASD diameter — never exceed this to avoid erosion
- Deficient retro-aortic rim (<5 mm): Higher erosion risk with ASO. Consider GORE Cardioform (no erosion reported) or specialized techniques
ASD Deployment Steps (Amplatzer ASO Technique)
- Venous access via right femoral vein
- Transseptal puncture (if not crossing through defect directly)
- Position TorqVue long sheath in left upper pulmonary vein (stable position)
- Size the defect (balloon stop-flow technique as above)
- Load the device into loader, connect to delivery cable (screwthread mechanism)
- Advance device through sheath into left atrium
- Open LA disc in left atrium, pull back to engage the septum
- Retract sheath to open RA disc in right atrium
- Perform "wiggle test" — push-pull maneuver under TEE/fluoroscopy to confirm stability
- Assess position: device must not impinge on SVC, pulmonary veins, mitral valve, or aorta
- If position stable → release device by counterclockwise rotation of delivery cable
- Confirm closure with color Doppler TEE
Left: balloon sizing measuring 11.88 mm. Right: GORE Cardioform fully deployed across the septum.
2. Ventricular Septal Defect (VSD) Closure
What is a VSD?
The most common congenital heart defect. Defects range from tiny pinholes to near-absence of the septum. Shunt magnitude depends on ventricular outflow resistance.
VSD locations:
| Type | Transcatheter Suitability |
|---|
| Muscular | ✅ Ideal for device closure |
| Perimembranous | ⚠️ Controversial — risk of complete AV block (2–6%) |
| Post-infarct | ✅ FDA-approved (Amplatzer Post-Infarct device) |
| Traumatic / Post-op residual | ✅ Device closure is reasonable alternative |
| Inlet | ❌ Not amenable — no circumferential tissue rim |
VSD Closure Devices
| Device | Key Features |
|---|
| Amplatzer Muscular VSD Occluder | Larger discs, short waist. For congenital muscular VSDs |
| Amplatzer Post-Infarct Muscular VSD Occluder | Larger discs + longer 10 mm waist to accommodate thicker adult interventricular septum. FDA-approved for post-MI VSD |
| Amplatzer Septal Occluder (off-label) | Sometimes used for post-infarct VSDs |
VSD Sizing and Deployment
Sizing:
- 2D/3D TEE in multiple views: RV inflow-outflow, parasternal short axis, apical 4-chamber
- Measure the defect diameter directly — balloon sizing not routinely needed for most VSDs (unlike ASD)
- Device size selected to be 1–2 mm larger than the measured defect
- Confirm adequate rim from aortic valve, TV, and MV
Deployment (Muscular VSD — Retrograde Approach):
- Femoral venous + arterial access
- Cross the VSD from the LV side (arterial, retrograde) with a wire
- Establish arteriovenous wire loop (snared from RV and exteriorized via femoral vein)
- Advance long delivery sheath from femoral vein, crossing VSD into LV
- Open LV disc in left ventricle
- Pull back to appose the septum
- Open RV disc in right ventricle
- Wiggle test, TEE confirmation of position
- Ensure no AV valve impingement, no aortic regurgitation
- Release device
Complications specific to VSD closure:
- Complete AV block (most feared — perimembranous VSDs)
- Aortic regurgitation (from device impinging on aortic valve)
- Tricuspid regurgitation
- Device embolization
3. Patent Ductus Arteriosus (PDA) Closure
What is a PDA?
Failure of the ductus arteriosus to close after birth. Causes left-to-right shunt (aorta → pulmonary artery), pulmonary overcirculation, LV dilation. Large PDAs → heart failure, atrial arrhythmias, pulmonary hypertension. Site for infective endarteritis.
PDA Closure Devices
Left to right: ADO-I (funnel-shaped plug), ADO-II (symmetric skirts), Amplatzer Vascular Plug II, Nit-Occlud coil, deployment fluoroscopy
| Device | PDA Type | Key Features |
|---|
| Amplatzer Duct Occluder I (ADO-I) | Conical/ampullary PDA | Nitinol mesh + Dacron polyester. Funnel-shaped with retention disc on aortic side. 6–9 Fr sheath. Sizes 3.5–14 mm |
| Amplatzer Duct Occluder II (ADO-II) | Any orientation | Symmetric retention skirts — can be placed antegrade or retrograde. No polyester fill (tighter nitinol weave) |
| Amplatzer Vascular Plug II (AVP-II) | Long tubular ducts | Low profile, sizes 3–22 mm. Works when duct is long enough to prevent LPA/aortic obstruction |
| Amplatzer Vascular Plug IV (AVP-IV) | Tortuous anatomy | Even lower profile, sizes 4–8 mm, slightly longer |
| Nit-Occlud (PFM Medical) | Small/moderate PDAs | Single nitinol wire coil in funnel shape. Delivered via 4 Fr catheter with controlled-release mechanism |
| Simple/detachable coils | Small PDAs | After crossing, simple or detachable coils reliably occlude small ducts |
PDA Sizing and Deployment
Sizing:
- Angiography (aortogram in lateral projection) is the gold standard: measures minimum PDA diameter, length, and shape (Type A–E Krichenko classification)
- TTE/TEE supplementary: measures minimum diameter, LPA/aortic end diameter
- Device size selected: ≥1–2 mm larger than the narrowest (minimum) PDA diameter
- For ADO-I: device diameter at pulmonary end should match the PDA minimum diameter +1–2 mm; the retention disc sits in the aortic ampulla
Deployment (Antegrade — ADO-I Standard Technique):
- Right femoral venous access; advance catheter across PDA from PA to descending aorta
- Establish guidewire in descending aorta
- Advance long delivery sheath into descending aorta
- Screw device onto delivery cable clockwise; load into sheath
- Advance device into descending aorta → retract sheath to open retention disc in aortic ampulla
- Pull sheath + cable back as one unit until retention disc is snug at aortic end of ampulla
- Retract sheath further into PA → tubular body and PA disc open within the duct
- Confirm position angiographically (no LPA or aortic obstruction) and by echocardiography
- Check for residual shunting with color Doppler
- Release device (counterclockwise rotation)
Overall PDA closure success rate: ~94%. Serious adverse events are rare.
Summary: Sizing Rules at a Glance
| Defect | Sizing Method | Device Size Selection |
|---|
| ASD | Balloon stop-flow (stretched diameter) + TEE static measurement | = Stop-flow diameter (max 1 size larger); never >1.5× static echo diameter |
| VSD | 2D/3D TEE direct measurement | 1–2 mm > measured defect diameter |
| PDA | Lateral aortogram minimum diameter | ≥1–2 mm > minimum (narrowest) PDA diameter |
Imaging Guidance During All Procedures
| Modality | Role |
|---|
| TEE | Primary real-time guidance — confirms device position, rules out impingement, checks residual shunt |
| ICE (Intracardiac Echo) | Alternative to TEE — avoids general anesthesia; growing use in adults |
| TTE | Pre/post procedure assessment; can be used in children |
| Fluoroscopy | Device delivery, balloon sizing measurement, angiography (especially for PDA) |
| 3D Echo | Best for defect morphology, rim assessment, device orientation |
Sources: Braunwald's Heart Disease, 12th Ed., Chapter 83 "Transcatheter Therapies for Congenital Heart Disease"; Textbook of Clinical Echocardiography, Chapter 17; Abbott/Amplatzer device instructions for use